scispace - formally typeset
P

Philip Ng

Researcher at Chiron Corporation

Publications -  8
Citations -  511

Philip Ng is an academic researcher from Chiron Corporation. The author has contributed to research in topics: NS3 & Antigen. The author has an hindex of 7, co-authored 8 publications receiving 509 citations. Previous affiliations of Philip Ng include Novartis.

Papers
More filters
Journal ArticleDOI

Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine

TL;DR: Evidence is provided that Core-ISCOM is effective at inducing cellular and humoral immune responses in nonhuman primates and that it could serve as an adjuvant for the HCV envelope protein E1E2.
Journal ArticleDOI

Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity

TL;DR: It is demonstrated that the chimpanzee not only developed protective immunity to the homologous type 1a RNA after rechall challenge by IHGI but was also protected from chronic HCV infection after sequential rechallenge with 100 50% chimpanzee infectious doses of a heterologoustype 1a (H77) and 1b (HC-J4) whole-virus inoculum.
Journal ArticleDOI

Cationic microparticles are a potent delivery system for a HCV DNA vaccine.

TL;DR: Cationic PLG microparticles with adsorbed HCV DNA generates potent immune responses, and PLG/DNA is selected for further evaluation in a non-human primate model.